Before phase (n =97) | After phase (n =102) | P -value | |
---|---|---|---|
Age, yr, median (IQR) | 58 (43 to 66) | 56 (41 to 64) | 0.332 |
Sex, n (%) | 0.372 | ||
Male | 50 (52%) | 59 (58%) | |
Female | 47 (48%) | 43 (42%) | |
Ethnicity, n (%) | 0.196 | ||
Caucasian | 59 (61%) | 57 (56%) | |
African American | 33 (34%) | 37 (36%) | |
Other | 3 (3%) | 0 (0%) | |
Not documented | 2 (2%) | 8 (8%) | |
Weight, kg, median (IQR) | 83 (66 to 97) | 86 (72 to 102) | 0.153 |
Intensive care unit, n (%) | |||
Surgical/trauma | 67 (69%) | 61 (60%) | 0.173 |
Medical | 30 (31%) | 41 (40%) | |
Reason for ICU admission, n (%) | |||
Surgical | 34 (35%) | 43 (42%) | 0.282 |
Medical | 36 (37%) | 40 (39%) | |
Trauma | 27 (28%) | 19 (19%) | |
APACHE II score,b median (IQR) | 21 (17–23) | 19 (16–24) | 0.800 |
Vasopressor at baseline, n (%) | 53 (55%) | 49 (48%) | 0.352 |
Reason for mechanical ventilation, n (%) | |||
Postoperative | 24 (25%) | 17 (17%) | 0.803 |
Chest trauma | 9 (9%) | 6 (6%) | |
Pneumonia | 11 (11%) | 11 (11%) | |
Severe sepsis | 21 (22%) | 18 (18%) | |
Cardiogenic pulmonary edema | 3 (3%) | 5 (5%) | |
PE | 2 (2%) | 3 (3%) | |
Asthma | 6 (6%) | 10 (10%) | |
Cardiac arrest | 1 (1%) | 1 (1%) | |
Airway protection | 15 (15%) | 22 (22%) | |
ARDS | 3 (3%) | 6 (6%) | |
Other | 2 (2%) | 3 (3%) | |
Past medical history, n (%) | |||
Hypertension | 49 (51%) | 54 (53%) | 0.732 |
Cardiac disease | 29 (30%) | 31 (30%) | 0.939 |
DM | 20 (21%) | 36 (35%) | 0.021 |
Asthma or COPD | 24 (25%) | 32 (31%) | 0.299 |
Malignancy | 16 (16%) | 17 (17%) | 0.974 |
End-stage renal disease | 5 (5%) | 6 (6%) | 1.0 |
Cirrhosis | 2 (2%) | 4 (4%) | 0.684 |
Number of spontaneous breathing trials per patient, median (IQR) | 3 (1 to 4) | 2 (1 to 5) | 0.870 |